Head, Oncology Immune Therapeutics

Novartis

Cambridge, MA, United States
Base: $288,400.00 - $535,600.00 usd annual; bonus/...
Onsite
Phd or md in oncology or immunology
Deep expertise in immuno-oncology and cell therapy
Experience leading end-to-end oncology research programs
This role defines and leads the global research and drug discovery strategy across cutting-edge modalities including cell and gene therapies

Job Summary

  • This role defines and leads the global research and drug discovery strategy across cutting-edge modalities including cell and gene therapies.
  • The successful candidate will drive a high-impact oncology pipeline spanning exploratory research, optimization, and clinical-enabling activities.
  • Novartis offers a comprehensive benefits package including health, life, disability benefits, 401(k) matching, and generous time off.

Matching Summary

This role defines and leads the global research and drug discovery strategy across cutting-edge modalities including cell and gene therapies.

Salary

Base: $288,400.00 - $535,600.00 USD Annual; Bonus/Equity: Performance-based cash incentive and annual equity awards eligible; Benefits: Comprehensive health, life, disability, 401(k) match, and time off

Skills & Requirements

Must-have

  • PhD or MD in oncology or immunology
  • Deep expertise in immuno-oncology and cell therapy
  • Experience leading end-to-end oncology research programs
  • Proven track record advancing biologics to IND stage
  • Leadership of large multidisciplinary scientific teams

Nice-to-have

  • Experience leading external scientific collaborations
  • Track record shaping enterprise-wide research strategy
  • Strong network across oncology research landscape
  • Ability to influence senior decision forums globally

Key Requirements

  • Doctor of Philosophy (PhD) or Medical Doctor (MD)
  • Extensive experience with chimeric antigen receptor T-cell therapies
  • Demonstrated leadership of large scientific teams

Work Rights

Not specified

Tailored Resume

Cover Letter